(FM) Inmunología
Departamento académico
Johns Hopkins University
Baltimore, Estados UnidosPublicaciones en colaboración con investigadores/as de Johns Hopkins University (5)
2024
-
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 3
2015
-
Enhancing T cell performance against cancer in combination treatment strategies
Cancer Drug Discovery and Development (Humana Press Inc.), pp. 245-258
-
Melanoma: From incurable beast to a curable bet. The success of immunotherapy
Frontiers in Oncology, Vol. 5, Núm. JUN
2011
-
Defining the critical hurdles in cancer immunotherapy
Journal of Translational Medicine
2009
-
Palettes of vaccines and immunostimulatory monoclonal antibodies for combination
Clinical Cancer Research